MB076 is an innovative heterocyclic triazole designed with enhanced plasma stability. It effectively inhibits seven distinct Class C Acinetobacter-derived cephalosporinases (ADCs) beta-lactamase variants with K i values less than 1 µM. Additionally, MB076 demonstrates a synergistic effect when combined with various cephalosporins to restore pBCSK(-) susceptibility [1].
Molecular Weight:
373.18
CAS Number:
[2832966-95-5]
Formula:
C9H12BN7O5S2
Target:
Others
T86864
* VAT and and shipping costs not included. Errors and price changes excepted
